Journal of ovarian research

J Ovarian Res · ISSN (e) 1757-2215 · 473 papers in corpus
observational 2026
doi:10.1186/s13048-026-02157-z ·PMID:42243891

BACKGROUND: Elective fertility preservation (EFP) is publicly funded in France, but little data is available about the socio-demographic profiles and motivations of women opting for this procedure, as well as on their perspective and levels…

meta-analysis 2026
doi:10.1186/s13048-026-02008-x ·PMID:41652526

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by ovulatory dysfunction and hormonal imbalance, often leading to infertility. Cangfu Daotan Decoction (CFDTT, Atractylodis Rhizoma, Cyperi Rhizoma, P…

review 2026
doi:10.1186/s13048-026-02112-y ·PMID:42035140

The convergence of immunogenetics and reproductive endocrinology highlights Tumor Necrosis Factor-alpha (TNF-α) as a central mediator of ovarian physiology. This review explores how variations in the TNF gene promoter contribute to the cont…

meta-analysis 2026
doi:10.1186/s13048-026-02073-2 ·PMID:41840684

BACKGROUND: Chronic hepatitis B (HBV) and hepatitis C (HCV) infections represent a substantial global health burden and increasing numbers of infertile women with chronic HBV/HCV infections seek conception through in vitro fertilization (IV…

observational 2026
doi:10.1186/s13048-026-02042-9 ·PMID:41787456

BACKGROUND: Insulin resistance (IR) is a key metabolic disturbance that adversely affects assisted reproductive technology (ART) outcomes. In women with polycystic ovary syndrome (PCOS), IR has been well documented to impair oocyte quality,…

diagnostic-accuracy 2025
doi:10.1186/s13048-025-01707-1 ·PMID:40481532

PURPOSE: To establish a diagnostic model combining contrast-enhanced ultrasound (CEUS), human epididymis protein 4 (HE4), and Ovarian-Adnexal Reporting and Data Systems (O-RADS) US v2022, verify its diagnostic efficacy, and compare it with …

meta-analysis 2025
doi:10.1186/s13048-024-01581-3 ·PMID:39980032

BACKGROUND: The positive effects of dehydroepiandrosterone (DHEA) on oocyte and embryo quality improvement are often concerned. While the results on DHEA-induced endometrial improvement are controversial. OBJECTIVE: To evaluate whether DHE…

review 2025
doi:10.1186/s13048-025-01921-x ·PMID:41354809

Ovarian cancer (OC) remains a highly lethal gynecologic malignancy characterized by substantial molecular heterogeneity and diagnostic challenges. Although many reviews examine specific aspects of OC biology or treatment, few attempt to con…

review 2025
doi:10.1186/s13048-025-01849-2 ·PMID:41299583

It is estimated that 70-75% of cancer survivors are interested in parenthood with an astounding 80% struggling with reduced fertility. Cancer treatments can deteriorate the ovarian primordial follicular pool and reduce the quality of fertil…

observational 2025
doi:10.1186/s13048-025-01885-y ·PMID:41310816

BACKGROUND: In assisted reproductive technology, preventing premature ovulation is crucial for achieving successful pregnancy outcomes. The traditional GnRH antagonist protocol is commonly used to suppress the luteinizing hormone (LH) surge…

other 2025
doi:10.1186/s13048-025-01732-0 ·PMID:40676609

BACKGROUND: The age-related decline of fertility is caused by a reduction of the ovarian reserve, which is represented by the number and quality of oocytes in the ovaries. Anti-Müllerian hormone (AMH) is considered one of the most useful ma…

observational 2025
doi:10.1186/s13048-025-01853-6 ·PMID:41250201

BACKGROUND: Ovarian maldescent is a rare congenital anomaly in which one or both ovaries are positioned abnormally above the pelvic brim. However, the potential relationship between ovarian maldescent and infertility remains poorly understo…

observational 2025
doi:10.1186/s13048-025-01629-y ·PMID:40011967

BACKGROUND: Infertility has become a world-wide public health problem. To identify women in a high-risk of infertility at an early stage when more treatments are available, early risk factors such as age at menarche (AAM) are being investig…

observational 2025
doi:10.1186/s13048-025-01720-4 ·PMID:40611162

BACKGROUND: Hyperuricemia (HUA) has become popular globally, being an important risk factor for various metabolic diseases. Elevated serum uric acid (UA) levels cause adverse reproductive outcomes in women with polycystic ovary syndrome und…

observational 2025
doi:10.1186/s13048-025-01594-6 ·PMID:39844271

BACKGROUND: To a large extent, the ovarian reserve determines a woman's reproductive potential. The etiological and pathological mechanisms of diminished ovarian reserve (DOR) remain unclear, and no reliable treatment is currently available…

observational 2025
doi:10.1186/s13048-025-01601-w ·PMID:39901170

BACKGROUND: Few previous studies have addressed the impact of COVID-19 infection status on assisted reproductive technology outcomes. The purpose of this study was to assess whether COVID-19 infection affects ovulation induction outcomes an…

review 2025
doi:10.1186/s13048-025-01784-2 ·PMID:40999527

The ovaries play essential roles in providing oocytes for fertilization and secreting sex hormones that regulate various organ functions. Autophagy has been implicated in the modulation of ovarian functions, yet its mechanisms of action are…

case-report 2025
doi:10.1186/s13048-025-01675-6 ·PMID:40317059

BACKGROUND: In clinical practice, borderline seromucinous ovarian tumor (SMBT) is hard to differentiate preoperatively on ultrasound. CASE: We presented a case of SMBT. In this case, microvascular imaging, particularly three-dimensional (3…

meta-analysis 2025
doi:10.1186/s13048-025-01900-2 ·PMID:41353542

Excessive androgens may lead to abnormal folliculogenesis and anovulation. To explore the link between hyperandrogenism (HA) and anovulation - related infertility, we performed a two - sample Mendelian randomization analysis, followed by mu…

observational 2025
doi:10.1186/s13048-025-01891-0 ·PMID:41327358

PURPOSE: To investigate the impact of changing to the PPOS protocol in the population with a premature progesterone increase (≥ 0.9 ng/mL) from the antagonist protocol on the clinical outcomes. METHODS: The study was a retrospective cohort,…

observational 2025
doi:10.1186/s13048-025-01721-3 ·PMID:40611317

BACKGROUND: Recurrent pregnancy loss (RPL) affects 1-2% of women worldwide and poses diagnostic and therapeutic challenges due to its multifactorial causes. Preimplantation genetic testing for aneuploidy (PGT-A) aims to improve outcomes by …

rct 2025
doi:10.1186/s13048-025-01702-6 ·PMID:40442814

BACKGROUND: This study compared the effectiveness of cabergoline and hydroxychloroquine in preventing ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCOS) undergoing controlled ovarian stimulation. MAT…

observational 2025
doi:10.1186/s13048-025-01800-5 ·PMID:41023667

BACKGROUND: The administration of exogenous gonadotropins (Gn) to elicit multi-follicular development for controlled ovarian stimulation (COS) represents a pivotal component of assisted reproductive technology (ART). Presently, the exogenou…

observational 2025
doi:10.1186/s13048-025-01665-8 ·PMID:40241198

BACKGROUND: Mosaic embryos have been proven to be capable of resulting in live births and have become an option for embryo transfer under certain circumstances. Recent guidelines suggested that embryo morphological scoring should be taken i…

observational 2025
doi:10.1186/s13048-025-01933-7 ·PMID:41457235

PURPOSE: To conduct a comparative metabolomic analysis of follicular fluid (FF) from patients undergoing in vitro fertilization (IVF) cycles under GnRH agonist versus antagonist protocols, aiming to identify protocol-specific metabolic sign…